Your browser doesn't support javascript.
loading
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial.
Woodcock, Ashley; Vestbo, Jørgen; Bakerly, Nawar Diar; New, John; Gibson, J Martin; McCorkindale, Sheila; Jones, Rupert; Collier, Susan; Lay-Flurrie, James; Frith, Lucy; Jacques, Loretta; Fletcher, Joanne L; Harvey, Catherine; Svedsater, Henrik; Leather, David.
Afiliación
  • Woodcock A; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester, UK. Electronic address: ashley.woodcock@manchester.ac.uk.
  • Vestbo J; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester, UK.
  • Bakerly ND; Salford Royal NHS Foundation Trust, Salford, UK.
  • New J; Salford Royal NHS Foundation Trust, Salford, UK; NorthWest EHealth, Salford, UK.
  • Gibson JM; Salford Royal NHS Foundation Trust, Salford, UK; NorthWest EHealth, Salford, UK; Manchester Academic Health Sciences Centre, University of Manchester and Salford Royal NHS Foundation Trust, Manchester, UK.
  • McCorkindale S; NHS Salford CCG, Salford, UK; NIHR Clinical Research Network Greater Manchester, Manchester, UK.
  • Jones R; Clinical Trials & Health Research, Peninsula School of Medicine and Dentistry, Plymouth University, Plymouth, UK.
  • Collier S; Respiratory Research and Development, GlaxoSmithKline, Uxbridge, UK.
  • Lay-Flurrie J; Respiratory Research and Development, GlaxoSmithKline, Uxbridge, UK.
  • Frith L; Respiratory Research and Development, GlaxoSmithKline, Uxbridge, UK.
  • Jacques L; Respiratory Research and Development, GlaxoSmithKline, Uxbridge, UK.
  • Fletcher JL; Respiratory Research and Development, GlaxoSmithKline, Uxbridge, UK.
  • Harvey C; Global Clinical Safety & Pharmacovigilance, Safety Evaluation and Risk Management, GlaxoSmithKline, Uxbridge, UK.
  • Svedsater H; Respiratory Research and Development, GlaxoSmithKline, Uxbridge, UK.
  • Leather D; Global Respiratory Franchise, GlaxoSmithKline UK Ltd, Brentford, UK.
Lancet ; 390(10109): 2247-2255, 2017 Nov 18.
Article en En | MEDLINE | ID: mdl-28903864
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / Alcoholes Bencílicos / Broncodilatadores / Clorobencenos / Fluticasona Tipo de estudio: Clinical_trials / Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / Alcoholes Bencílicos / Broncodilatadores / Clorobencenos / Fluticasona Tipo de estudio: Clinical_trials / Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article